Pacemaker implant site infection caused by atypical mycobacteria

Indian Heart Journal

Volumn 50, Issue 2, 1998, Pages 201-202

  Verghese, Susan ^a   Mullaseri, Ajit ^a   Padmaja, P ^a   Subhadra, A C ^a   Cherian, K M ^a  

^a INSTITUTE OF CARDIOVASCULAR DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; OFLOXACIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATYPICAL MYCOBACTERIUM; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE REPORT; HUMAN; IMPLANTATION; MALE; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; REIMPLANTATION;

AGED; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; PACEMAKER, ARTIFICIAL; REOPERATION; SURGICAL WOUND INFECTION;

EID: 0031744938     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Graux P, Lequeuche B, Guyomar Y, Carlioz R, Delfaut P, Beaugeard D, et al. Multifactor prevention of endocarditis and cardiac pacemakers: A prospective study apropos of 207 patients. Ann Cardiol, Angeiol (Paris) 1996; 45: 113-118
2. Lee JH, Geha AS, Rattehalli NM, Cmolik BL, Johnson NJ, Biblo LA, et al. Salvage of infected ICDS: Management without removal. Pacing Clin Electrophysiol 1996; 19: 437-442
3. Leprince P, Nataf P, Cacoub P, Jault F, Goignard E, Bors V, et al. Septicemia and endocarditis related to transvenous pacing leads of pacemakers: Surgical indications and results. Arch Mal Coeur Vaiss 1995; 88: 241-246
4. Horowitz EA, Sanders WE. Other mycobacterium species. In Principles & Practices of Infectious Diseases. Mandell GL, Bennett JE, Dolin R, ed. 4th Edn. Churchill Livingstone Inc., New York 1995; p 2270
5. Du Moulin GC, Stottmeier KD. Water borne mycobacteria: An increasing threat to health ASM News 1986; 52: 525-529
6. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of mycobacterium fortuitum complex. Ann Intern Med 1983; 98: 938-939
7. Pring M, Eckhoff DG. Mycobacterium chelonea infection following a total knee arthroplasty. J Arthroplasty 1996; 11: 115-116
8. Camargo D, Saad C, Ruiz F, Ramirez ME, Lineros M, Rodiguez G, et al. Iatrogenic outbreak of M. chelonea skin abscesses. Epidemiol Infect 1996; 117: 113-119
9. Wright JE. Non-tuberculous mycobacterial lymphadenitis. Aust NZ J Surg 1996; 66: 225-228
10. Hernandez Garcia AM, Arias A, Felipe A, Alvarez R, Sierra A. In vitro sensitivity of mycobacterium chelonea strains to various antimicrobial agents. Microbiologie 1995; 11: 485-490
11. Choudhri S, Manfreda J, Wolfe J, Parker S, Long R. Clinical significance of non-tuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 1995; 21: 128-133